Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey

Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey Publisher Pubmed

Khezri M¹ ; Karamouzian M^{1, 2} ; Sharifi H¹ ; Ghalekhani N¹ ; Tavakoli F¹ ; Mehmandoost S¹ ; Mehrabi F¹ ; Pedarzadeh M³ ; Nejat M⁴ ; Noroozi A⁵ ; Baral S⁶ ; Shokoohi M^{1, 7}

Show Affiliations

1. HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
2. School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
3. Center for HIV/STI Control and Prevention, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4. Shiraz University of Medical Sciences, Shiraz, Iran
5. Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
6. Department of Epidemiology, Johns Hopkins University School of Public Health, Baltimore, MD, United States
7. Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, M5T 3M7, ON, Canada

Source: International Journal of Drug Policy Published:2021

Abstract

Background: Supervised injection facilities (SIFs) have not yet been integrated into Iran's harm reduction programs. This study aimed to report the extent to which people who inject drugs (PWID) in Iran are willing to use SIFs. Methods: Participants were recruited from 11 major cities using respondent-driven sampling. Willingness to use SIFs was defined as a three-level categorical variable: low, moderate, or high. Results: Of 2,490 PWID, 52.8% and 23.8% reported high and moderate willingness to use SIFs, respectively. PWID with a history of homelessness (relative-risk ratio (RRR): 2.22, 95% CI: 1.76–2.80), incarceration (1.86 [1.48–2.35]), hepatitis C infection (1.49 [1.13–1.97]), and non-fatal overdose (2.30 [1.69–3.13]) were more likely to be willing to utilize SIFs. Willingness to use SIFs was also higher among PWID who reported recent public injecting (2.24 [1.70–2.97]), daily injection (1.82 [1.35–2.45]), stimulants injection (2.39 [1.41–4.07]), syringe sharing (3.09 [1.23-7.74]), harm reduction services utilization (2.80 [2.13–3.68]), and food insecurity (8.28 [5.43-12.63]). Conclusion: The majority of PWID in Iran expressed willingness to use SIFs, in particular, those who were involved in higher-risk injection practices, dealing with structural risks, and had experienced drug-related harms. SIFs represent critical opportunities to deliver comprehensive harm reduction services to improve the health and well-being of PWID in Iran. © 2021 Elsevier B.V.

Related Docs

View other Related Docs

1. Public Injecting and Its Association With Mental Health and Other Drug-Related Outcomes Among People Who Inject Drugs in Iran, Journal of Substance Abuse Treatment (2022)

2. Characterizing People Who Inject Drugs With No History of Opioid Agonist Therapy Uptake in Iran: Results From a National Bio-Behavioural Surveillance Survey in 2020, International Journal of Mental Health and Addiction (2022)

3. Hiv Prevention Cascades for Injection and Sexual Risk Behaviors Among Hiv-Negative People Who Inject Drug in Iran, International Journal of Drug Policy (2020)

4. How Substance Use Treatment Services in Iran Survived Despite a Dual Catastrophic Situation, American Journal of Public Health (2022)

5. Buprenorphine Abuse and Health Risks in Iran: A Systematic Review, Drug and Alcohol Dependence (2021)

6. Hepatitis B Virus Infection Among People Who Use Drugs in Iran: A Systematic Review, Meta-Analysis, and Trend Analysis, Harm Reduction Journal (2020)

7. Association of Abcb1, Μ-Opioid Receptor, and Cytochrome P450 Genes With Methadone Dose in Iranian Male Addicts Under Methadone Therapy, Basic and Clinical Neuroscience (2024)

8. Public Health Risks Associated With Methadone in Iran: A Systematic Review and Meta-Analysis, International Journal of Drug Policy (2022)

Experts (# of related papers)

View all Related Experts

Afarin Rahimi-Movaghar (5)

Jaleh Gholami (4)

Style	Citing Format
MLA	Khezri M, et al.. "Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey." International Journal of Drug Policy, vol. 97, no. , 2021, pp. -.
APA	Khezri M, Karamouzian M, Sharifi H, Ghalekhani N, Tavakoli F, Mehmandoost S, Mehrabi F, Pedarzadeh M, Nejat M, Noroozi A, Baral S, Shokoohi M (2021). Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey. International Journal of Drug Policy, 97(), -.
Chicago	Khezri M, Karamouzian M, Sharifi H, Ghalekhani N, Tavakoli F, Mehmandoost S, Mehrabi F, et al.. "Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey." International Journal of Drug Policy 97, no. (2021): -.
Harvard	Khezri M et al. (2021) 'Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey', International Journal of Drug Policy, 97(), pp. -.
Vancouver	Khezri M, Karamouzian M, Sharifi H, Ghalekhani N, Tavakoli F, Mehmandoost S, et al.. Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey. International Journal of Drug Policy. 2021;97():-.
BibTex	@article{ author = {Khezri M and Karamouzian M and Sharifi H and Ghalekhani N and Tavakoli F and Mehmandoost S and Mehrabi F and Pedarzadeh M and Nejat M and Noroozi A and Baral S and Shokoohi M}, title = {Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey}, journal = {International Journal of Drug Policy}, volume = {97}, number = {}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Khezri M AU - Karamouzian M AU - Sharifi H AU - Ghalekhani N AU - Tavakoli F AU - Mehmandoost S AU - Mehrabi F AU - Pedarzadeh M AU - Nejat M AU - Noroozi A AU - Baral S AU - Shokoohi M TI - Willingness to Utilize Supervised Injection Facilities Among People Who Inject Drugs in Iran: Findings From 2020 National Hiv Bio-Behavioral Surveillance Survey JO - International Journal of Drug Policy VL - 97 IS - SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract